Wegovy Price Check: What Private Treatment Costs in the UK

Free clinical consultation, personally reviewed by a GPhC-registered Independent Prescriber
Prescription issued at no additional charge if clinically approved
Free next-working-day tracked DPD delivery in plain, unbranded packaging
Priority aftercare available seven days a week, with clinical re-review before every repeat order

Wegovy (semaglutide) is a prescription-only medicine for weight management, and private prices in the UK vary considerably by dose and provider. Since Novo Nordisk adjusted UK supply and pricing through 2024–25, the private market has settled into a broad range — typically somewhere between £149 and £375 per month depending on which dose you're prescribed and where you get it. That figure comes hedged, because real costs depend on what's bundled in. Wegovy requires a clinical assessment before any prescription can be issued, and the prescriber (not the price tag) decides whether it's appropriate for you.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How Wegovy pricing works in practice — and what to look for beyond the headline number

What the NICE guidance and clinical trials tell us about what you're actually paying for

NICE recommended semaglutide (Wegovy) for weight management in March 2023, and the trial that underpinned it (the STEP 1 study, published in the New England Journal of Medicine) reported an average body-weight reduction of around 15% over 68 weeks among adults treated with the 2.4mg weekly dose alongside lifestyle changes. That's a significant clinical result, and it helps explain why demand has outpaced supply in the UK since launch.

What NICE's recommendation also tells you is that the full benefit only emerges over time, across a carefully titrated dose schedule, with consistent clinical oversight. You start at 0.25mg and work upward over roughly five months before reaching the 2.4mg maintenance dose. The NHS semaglutide page sets out what that journey looks like at a patient level. If you want to understand the full-course cost before committing, our Wegovy price guide breaks down what you can expect to pay across each stage of the titration, which is a more honest unit of comparison than a per-pen price quoted in isolation.

A question our prescribers hear most weeks is whether it's safe to start at a higher dose to save money on early pens. The short answer from a clinical standpoint is no: the titration schedule exists to reduce gastrointestinal side effects, and skipping steps is not how this medicine is intended to work.

What headline Wegovy prices often leave out

Private weight-loss treatment pricing in the UK varies because providers bundle different things. A low headline number can be accurate and still misleading if it covers only the medicine itself. Common additions that may not be reflected in the number you first see include the initial consultation fee, the prescription charge, delivery, and access to clinical support between doses.

Aftercare matters more than it sounds. If nausea hits hard in the first two weeks, or you have a question before your next dose, having a prescriber you can actually reach changes the experience considerably. The same goes for dose-increase reviews, a legitimate provider checks in clinically before moving you up, rather than auto-renewing at the next strength.

You can explore the full cost picture for Wegovy in more detail, including what varies by dose level and why. For context on how the 1mg dose specifically is priced and positioned in a titration pathway, the 1mg price breakdown walks through that step in isolation. If you want to compare providers, this page on the cheapest Wegovy options gives an honest read on what low-cost listings typically include.

Where nume sits on price, and why that's a deliberate choice

We're transparent about this: a cheaper monthly price for Wegovy exists somewhere. We don't try to match it. One price at nume covers the clinical consultation, the prescription, the treatment, next-working-day tracked delivery via DPD, and seven-day aftercare, nothing is unbundled, nothing added at checkout. No subscription, no auto-renewal; every repeat order goes back to a prescriber for fresh review.

Our clinical team, led by a GPhC-registered Independent Prescriber, reads every consultation personally on the day it's submitted. Before a dose increase is approved, we ask for evidence that the current dose has been tolerated and that the clinical picture supports moving up. That's not a bureaucratic hurdle, it's how responsible prescribing works for a medicine in this class.

Treatment pricing is published on the treatment page, and there are no extra charges beyond what's listed. If you'd like a broader sense of how Wegovy works as a treatment, including how it fits into the wider private weight-loss landscape, the weight-loss overview covers both injection options and the newer oral semaglutide tablet.

Why the lowest Wegovy price is usually the wrong thing to optimise for

Wegovy is a prescription-only medicine under the Human Medicines Regulations. The MHRA has warned publicly (and repeatedly) about counterfeit weight-loss pens sold online, including fake semaglutide products that have contained insulin rather than the stated medicine. Enforcement in 2025 involved the seizure of around 20 million doses of illegally traded weight-loss medicines worth approximately £45 million. You can verify any online pharmacy against the GPhC register at pharmacyregulation.org before purchasing.

A seller offering Wegovy at a strikingly low price, without a documented clinical assessment, or promoting discount codes on a prescription medicine, is a pattern the MHRA flags as a warning sign. Reporting a suspect seller via the MHRA Yellow Card scheme is straightforward and genuinely useful. For a medicine that works over months alongside diet and activity changes, the question worth asking isn't which provider is cheapest today, it's which one will still be clinically reviewing your case when you reach 7.5mg. If you'd like to see how current costs stack up across providers before deciding, our Wegovy price checker gives you a clear side-by-side picture. Our FAQs cover common questions about the service if you'd like more before booking. When you're ready, the next step is a free consultation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions